Q5RZ08 (Q5RZ08_9HIV1) Human immunodeficiency virus 1

Protease UniProtKBInterProInteractive Modelling

99 aa; Sequence (Fasta) ; 14 identical sequences

Available Structures

30 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal Structure of HIV-1 Protease (Q7K) in Complex with Lopinavir Heteromer
P03367;
CL;AB1;GOL;1-99
Assess
Crystal Structure of HIV-1 Protease (Q7K) in Complex with Atazanavir Heteromer
P03367; Q903J0;
CL;DR7;1-99
Assess
Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor Heteromer
Q9Q288; Q9Q2G8;
3TL;1-99
Assess
X-ray crystal structure of bPI-11 hiv-1 protease complexhomo-2-merGOL;SO4;B0F;CL;1-99
Assess
HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETShomo-2-merCL;1-99
Assess
HIV-1 wild type protease with GRL-03314A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as t…homo-2-merGR8;NA;CL;GOL;ACT;1-99
Assess
HIV-1 wild type protease with GRL-03119A, with phenyl-boronic-acid as P2'-ligand and with a hexahyd…homo-2-merB4R;NA;CL;FMT;GOL;1-99
Assess
HIV-1 wild type protease with GRL-03214A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as t…homo-2-merNA;CL;GOL;GR5;ACT;1-99
Assess
HIV-1 wild type protease with GRL-00819A, with phenyl-boronic-acid as P2'-ligand and with a 6-5-5-r…homo-2-merNA;CL;FMT;GOL;Q1D;1-99
Assess
Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10033homo-2-merO33;GOL;1-99
Assess
HIV-1 protease I84V, L90M with TMC126homo-2-merDJR;1-99
Assess
Crystal structure of WT HIV-1 protease with GS-8373homo-2-merQFI;1-99
Assess
HIV-1 Protease I84V, L90M with GS-8374homo-2-merKGQ;1-99
Assess
HIV-1 protease WT with GS-8374homo-2-merKGQ;1-99
Assess
P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi…homo-2-mer4AH;1-99
Assess
P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi…homo-2-mer2AH;1-99
Assess
INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF…homo-2-merA77;1-99
Assess
Crystal Structure of HIV-1 Protease (Q7K) in Complex with Tipranavirhomo-2-merTPV;GOL;1-99
Assess
Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based…homo-2-merUX9;1-99
Assess
Synthesis and Activity of N-Axyl Azacyclic Urea HIV-1 Protease Inhibitors with High Potency Against…homo-2-merAAU;1-99
Assess
Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I ) in Complex with KNI-10075homo-2-mer075;GOL;1-99
Assess
HIV-1 protease in complex with symmetric inhibitor, BEA450homo-2-merBLL;1-99
Assess
HIV-1 protease in complex with asymmetric inhibitor, BEA568homo-2-mer568;1-99
Assess
HIV Protease with inhibitor AB-2homo-2-merAB2;1-99
Assess
VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASEhomo-2-mer1UN;1-99
Assess
HIV-1 protease in complex with inhibitor AHA455homo-2-merA1A;1-99
Assess
P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi…homo-2-mer1AH;1-99
Assess
ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESU…homo-2-merL75;1-99
Assess
Crystal structure of HIV-1 protease complexed with Lopinavir.homo-2-merAB1;1-99
Assess
The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavirhomo-2-merBME;AB1;1-99
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
homo-2-merA85;0.851dif.1.A1-99
100.00
Assess

Alignments